The neu oncogene product in serum and tissue of patients with metastatic gastrointestinal carcinomas

Journal of Cancer Research and Clinical Oncology

Volumn 122, Issue 2, 1996, Pages 118-121

  Vogel, W ^a   Kath, R ^a   Kosmehl, H ^a   Olschowsky, E ^a   Hoffken K ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

c erbB 2; Colorectal cancer; Gastrointestinal carcinoma; HER 2; neu; p185

Indexed keywords

ENDOGENOUS COMPOUND;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MALE; ONCOGENE NEU; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM METASTASIS; RECEPTOR, ERBB-2;

EID: 0030029007     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01226269     Document Type: Article

References (26)

1. Akiyama T, Sudo CH, Ogawara H, et al (1986) The product of the human c-erbB-2 gene: a 185 kilodalton glycoprotein with tyrosine kinase activity. Science 232: 1644-1646
2. Arnaout AH, Dawson PM, Soomro S, et al (1992) HER2 (c-erbB-2) oncoprotein expression in colorectal adenocarcinoma: an immunohistological study using three different antibodies. J Clin Pathol 45: 726-727
3. Carney WP, Hamer PJ, Petit D, et al (1991) Detection and quantitation of the human neu oncoprotein. J Tumor Marker Oncol 6: 53-72
4. Coussens L, Yang-Feng TL, Liao YC, et al (1985) Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 230: 1132-1139
5. D'Emilia J, Bulovas K, D'Ercole K, et al (1989) Expression of the c-erbB-2 gene product (p185) at different stages of neoplastic progression in the colon. Oncogene 4: 1233-1239
6. Hayes DF, Carney W, Tondini C, et al (1989) Elevated circulating c-neu oncogene product in patients with breast cancer. Breast Cancer Res Treat 14: 135
7. Jaehne J, Urmbacher C, Thaler HT, et al (1992) Expression of HER2/ neu oncogene product p185 in correlation to clinicopathological and prognostic factors of gastric cacinoma. J Cancer Res Clin Oncol 118: 474-479
8. Kath R, Höffken K, Otte C, et al (1993) The neu oncogene product in serum and tissue of patients with breast carcinoma. Ann Oncol 4: 585-590
9. Kluftinger AM, Robinson BW, Quenville NF, et al (1992) Correlation of epidermal growth factor receptor and c-erbB-2 oneogene product to known prognostic indicators of colorectal cancer. Surg Oncol 1: 97-105
10. Kynast B, Binder L, Marx D, et al (1993) Determination of a fragment of the C-erbB-2 translational product p185 in serum of breast cancer patients. J Cancer Res Clin Oncol 119: 249-252
11. Lin YJ, Clinton GM (1991) A soluble protein related to the HER-2 proto-oneogene product is released from human breast carcinoma cell lines. Oncogene 6: 639-643
12. McCann A, Dervan PA, Johnston PA, et al (1990) c-erbB-2 oncoprotein expression in primary human tumors. Cancer 65: 88-92
13. McKenzie SJ, Marks PJ, Lam T, et al (1989) Generation and characterization of monoclonal antibodies specific for the human neu oncogene product, p185. Oncogene 4: 543-548
14. Meden H, Marx D, Hammadi H, et al (1992) Immunohistochemically detected oncoprotein p185/neu in ovarian cancer: a new prognosis factor? In: Klapdor R (ed) Tumor associated antigens, oncogenes. receptors, cytokines in tumor diagnosis and therapy a the beginning of the nineties. Zuekschwerdt, München Bern Berlin pp 431-432
15. Mizutani T, Onda M, Tokunaga A, et al (1993) Relationship of c-erbB-2 protein expression and gene amplification to invasion and metastasis in human gastric cancer. Cancer 72: 2083-2088
16. Nakamura T, Nekarda H, Hoelscher AH, et al (1994) Prognostic value of DNA ploidy and c-erbB-2 oncoprotein overexpression in adenocarcinoma of Barrett's esophagus. Cancer 73: 1785-1794
17. Sasaki K, Tomita Y, Azuma M, et al (1992) Amplification and overexpression of the c-erbB-2 protooncogene in human gastric cancer. Gastroenterol Jpn 27: 172-178
18. Schechter AL, Stern DF, Vaidyanathan L, et al (1984) The neu oncogene: an erb-B-related gene encoding a 185,000-M tumor antigen. Nature 312: 513-516
19. Slamon DJ, Clark GM, Wong SG, et al (1987) Human breast cancer correlation of relapse and survival with amplification of the HER-2/ neu oncogene. Science 235: 177-182
20. Slamon DJ, Godolphin W, Jones LA, et al (1989) Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244: 707-712
21. Tateishi M, Ishida T, Mitsudomi T, et al (1991) Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinoma. Eur J Cancer 27: 1372-1375
22. Uchino S, Tsudu H, Maruyama K, et al (1993) Overexpression of c-erbB-2 protein in gastric cancer. Its correlation with long-term survival of patients. Cancer 72: 3179-3184
23. Vogelstein B, Fearon ER, Hamilton SR, et al (1988) Genetic alterations during colorectal-tumor development. N Engl J Med 319: 525-532
24. Wu JT, Astill ME, Zhang P (1993) Detection of the extracellular domain of c-erbB-2 oncoprotein in sera from patients with various carcinomas: correlation with tumor markers. J Clin Lab Anal 7: 31-40
25. Yonemura Y, Ninomiya I, Yamaguchi A, et al (1991) Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short term prognosis in gastric cancer. Cancer Res 51: 1034-1038
26. Zabrecky JR, Lam T, McKenzie SJ, et al (1991) The extracellular domain of p185/neu is released from the surface of human breast carcinoma cells. SK-BR-3. J Biol Chem 266: 1716-1720